VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 546B
Enterprise Value 342.32B
Trailing P/E 204.19
Forward P/E 139.50
PEG Ratio (5 yr expected) 10.84
Price/Sales (ttm)19.05
Price/Book (mrq)19.16
Enterprise Value/Revenue 317.52
Enterprise Value/EBITDA 691.26

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 9.36%
Operating Margin (ttm)16.60%

Management Effectiveness

Return on Assets (ttm)7.26%
Return on Equity (ttm)3.37%

Income Statement

Revenue (ttm)2.41B
Revenue Per Share (ttm)9.63
Quarterly Revenue Growth (yoy)-10.30%
Gross Profit (ttm)1.05B
EBITDA 463.7M
Net Income Avi to Common (ttm)226M
Diluted EPS (ttm)0.88
Quarterly Earnings Growth (yoy)-15.10%

Balance Sheet

Total Cash (mrq)2.48B
Total Cash Per Share (mrq)9.72
Total Debt (mrq)595.12M
Total Debt/Equity (mrq)24.48
Current Ratio (mrq)3.68
Book Value Per Share (mrq)9.42

Cash Flow Statement

Operating Cash Flow (ttm)831.91M
Levered Free Cash Flow (ttm)541.6M

Trading Information

Stock Price History

Beta 1.92
52-Week Change 337.97%
S&P500 52-Week Change 313.79%
52 Week High 3181.60
52 Week Low 3127.67
50-Day Moving Average 3158.53
200-Day Moving Average 3159.86

Share Statistics

Avg Vol (3 month) 31.66M
Avg Vol (10 day) 31.41M
Shares Outstanding 5254.83M
Float 254.28M
% Held by Insiders 10.44%
% Held by Institutions 197.21%
Shares Short (Jun 15, 2018) 43.27M
Short Ratio (Jun 15, 2018) 42.07
Short % of Float (Jun 15, 2018) 41.44%
Short % of Shares Outstanding (Jun 15, 2018) 41.28%
Shares Short (prior month May 15, 2018) 43.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 24, 2000